The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A groundbreaking study reveals that ultrasensitive ctDNA assays significantly enhance prognosis for large B-cell lymphoma, outperforming traditional PET assessments.

Actor Kang Rae-yeon drew fans' concerns by telling them about her recent situation ahead of thyroid cancer surgery.On the ...

Actor Kang Rae-yeon shared her recent status after cancer surgery.Kang Rae-yeon said on the 2nd that it's a simple surgery, ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

How do tertiary lymphoid structures influence immunotherapy outcomes in Merkel cell carcinoma? Spatial proteomics reveals key ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Researchers sought to determine whether zanubrutinib plus obinutuzumab would be effective in treating patients with R/R FL. Researchers determined zanubrutinib plus obinutuzumab demonstrated sustained ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...